Company expands geographic presence across the Hawaiian Islands, enhancing product offerings for local customers
MELVILLE, N.Y. – March 4, 2025 – Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that it has acquired R. Weinstein, Inc. (R. Weinstein), a provider of vaccines, medical-surgical products, and equipment to Hawaii-based health care facilities and practitioners.
Headquartered in Honolulu, R. Weinstein was established in 1984 and reported sales of approximately $11 million in 2024. The financial terms of the transaction were not disclosed.
The acquisition of R. Weinstein strengthens Henry Schein’s presence across the Hawaiian Islands while offering R. Weinstein’s customers access to the Company’s expanded distribution network and comprehensive portfolio of products, services, technology, and supply chain solutions.
“Our investment in R. Weinstein helps position us for long-term success across the Hawaiian health care sector by expanding our geographic footprint, growing our customer base, and leveraging the expertise of our new colleagues,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “We welcome the R. Weinstein team and look forward to continuing to help Hawaii-based health care practitioners deliver the best quality patient care while operating more efficient and profitable practices.”
“The R. Weinstein team is excited to join Team Schein, a company that shares our commitment to serve Hawaii’s health care professionals,” said Jeff Weinstein, President, R. Weinstein. “Together, we will continue to drive growth for our customers, ensuring that our local communities receive the highest quality care possible.”
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.
For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.
CONTACT:
Investors
Ronald N. South
Senior Vice President and Chief Financial Officer
ronald.south@henryschein.com
(631) 843-5500
Graham Stanley
Vice President, Investor Relations and Strategic Financial Project Officer
graham.stanley@henryschein.com
(631) 843-5500
Media
Tim Vassilakos
Executive Director, Global Corporate Communications & Customer Experience
timothy.vassilakos@henryschein.com
(516) 510-0926